Agata Cova Selected Research

Agata Cova Research Topics

Disease

16	Neoplasms (Cancer) 01/2022 - 10/2002
12	Melanoma (Melanoma, Malignant) 01/2021 - 10/2002
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2021
1	Carcinogenesis 01/2019
1	Lung Neoplasms (Lung Cancer) 01/2019
1	Mucositis 12/2016
1	Head and Neck Neoplasms (Head and Neck Cancer) 12/2016
1	Stomatitis 12/2016
1	Lymphoma (Lymphomas) 01/2016
1	Multiple Myeloma 01/2016
1	Adenocarcinoma 05/2004
1	Carcinoma (Carcinomatosis) 10/2003
1	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 02/2003

Drug/Important Bio-Agent (IBA)

8	Peptides (Polypeptides)IBA 05/2013 - 04/2003
5	MART-1 AntigenIBA 05/2006 - 02/2003
4	HLA-A*02:01 antigenIBA 05/2013 - 04/2003
4	AntigensIBA 05/2013 - 02/2003
3	VaccinesIBA 08/2006 - 10/2002
2	Immune Checkpoint InhibitorsIBA 01/2021 - 12/2018
2	MicroRNAs (MicroRNA)IBA 01/2019 - 12/2018
2	Interleukin-2 (IL2)IBA 05/2013 - 04/2003
2	EpitopesIBA 03/2009 - 04/2003
2	vitespinIBA 08/2006 - 10/2002
2	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 08/2006 - 05/2004
2	Heat-Shock Proteins (Heat-Shock Protein)IBA 08/2006 - 10/2002
1	Antineoplastic Agents (Antineoplastics)IBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2021
1	Indicators and Reagents (Reagents)IBA 12/2018
1	InterleukinsIBA 12/2016
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2016
1	Interleukin-6 (Interleukin 6)IBA 12/2016
1	CytokinesIBA 12/2016
1	Death Domain ReceptorsIBA 01/2016
1	Propidium (Propidium Iodide)IBA 01/2016
1	TNF-Related Apoptosis-Inducing LigandIBA 01/2016
1	Annexin A5IBA 01/2016
1	Caspase 3 (Caspase-3)IBA 01/2016
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 05/2013
1	Cancer VaccinesIBA 12/2012
1	HLA Antigens (Human Leukocyte Antigens)IBA 12/2012
1	HLA-A2 Antigen (HLA A2 Antigen)IBA 03/2009
1	EnzymesIBA 08/2006
1	Interferon-alpha (Interferon Alfa)IBA 08/2006
1	sarcoma glycoprotein gp96 rejection antigensIBA 10/2003
1	Epithelial Cell Adhesion MoleculeIBA 10/2003
1	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 04/2003
1	LigandsIBA 04/2003
1	Immunodominant EpitopesIBA 04/2003
1	Melanoma-Specific AntigensIBA 10/2002

Therapy/Procedure

7	Therapeutics 01/2022 - 06/2012
4	Immunotherapy 01/2021 - 02/2003
1	Immunomodulation 01/2021
1	Aftercare (After-Treatment) 12/2016
1	Drug Therapy (Chemotherapy) 12/2016
1	Radiotherapy 12/2016